3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide

C114H128Cl5F3N44O18S — CID 162002275

IUPAC3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide
SMILESCOc1ccc(-c2noc(CCC(=O)N3CCC4(CC3)CN=C(NC(=O)c3nc(Cl)c(N)nc3N)N4)n2)cc1.CS(=O)(=O)c1ccc(CC(=O)N2CCC3(CC2)CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N3)cc1.Nc1nc(N)c(C(=O)NC2=NC3(CC2)CCN(C(=O)CCc2cc(-c4ccccc4)no2)CC3)nc1Cl.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)COc4ccc(OC(F)(F)F)cc4)CC3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)Cc4ccc(N5CCNC5=O)cc4)CC3)N2)nc1Cl
InChIInChI=1S/C25H27ClN8O3.C24H27ClN10O4.C23H27ClN10O3.C21H22ClF3N8O4.C21H25ClN8O4S/c26-21-23(28)31-22(27)20(30-21)24(36)29-18-8-9-25(32-18)10-12-34(13-11-25)19(35)7-6-16-14-17(33-37-16)15-4-2-1-3-5-15;1-38-14-4-2-13(3-5-14)21-29-15(39-34-21)6-7-16(36)35-10-8-24(9-11-35)12-28-23(33-24)32-22(37)17-19(26)31-20(27)18(25)30-17;24-17-19(26)30-18(25)16(29-17)20(36)31-21-28-12-23(32-21)5-8-33(9-6-23)15(35)11-13-1-3-14(4-2-13)34-10-7-27-22(34)37;22-15-17(27)30-16(26)14(29-15)18(35)31-19-28-10-20(32-19)5-7-33(8-6-20)13(34)9-36-11-1-3-12(4-2-11)37-21(23,24)25;1-35(33,34)13-4-2-12(3-5-13)10-14(31)30-8-6-21(7-9-30)11-25-20(29-21)28-19(32)15-17(23)27-18(24)16(22)26-15/h1-5,14H,6-13H2,(H4,27,28,31)(H,29,32,36);2-5H,6-12H2,1H3,(H4,26,27,31)(H2,28,32,33,37);1-4H,5-12H2,(H,27,37)(H4,25,26,30)(H2,28,31,32,36);1-4H,5-10H2,(H4,26,27,30)(H2,28,31,32,35);2-5H,6-11H2,1H3,(H4,23,24,27)(H2,25,28,29,32)
InChIKeyYSJHOFFRPGZSGJ-UHFFFAOYSA-N
MW2668.89 g/mol
LogP5.33
Rot. Bonds24

About 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide

3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide (PubChem CID 162002275) has the molecular formula C114H128Cl5F3N44O18S and a molecular weight of 2668.89 g/mol. Its IUPAC name is 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide.

Molecular Properties

Compound Name3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide
PubChem CID162002275
Molecular FormulaC114H128Cl5F3N44O18S
Molecular Weight2668.89 g/mol
Exact Mass2664.86
IUPAC Name3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide
SMILESCOc1ccc(-c2noc(CCC(=O)N3CCC4(CC3)CN=C(NC(=O)c3nc(Cl)c(N)nc3N)N4)n2)cc1.CS(=O)(=O)c1ccc(CC(=O)N2CCC3(CC2)CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N3)cc1.Nc1nc(N)c(C(=O)NC2=NC3(CC2)CCN(C(=O)CCc2cc(-c4ccccc4)no2)CC3)nc1Cl.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)COc4ccc(OC(F)(F)F)cc4)CC3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)Cc4ccc(N5CCNC5=O)cc4)CC3)N2)nc1Cl
InChIInChI=1S/C25H27ClN8O3.C24H27ClN10O4.C23H27ClN10O3.C21H22ClF3N8O4.C21H25ClN8O4S/c26-21-23(28)31-22(27)20(30-21)24(36)29-18-8-9-25(32-18)10-12-34(13-11-25)19(35)7-6-16-14-17(33-37-16)15-4-2-1-3-5-15;1-38-14-4-2-13(3-5-14)21-29-15(39-34-21)6-7-16(36)35-10-8-24(9-11-35)12-28-23(33-24)32-22(37)17-19(26)31-20(27)18(25)30-17;24-17-19(26)30-18(25)16(29-17)20(36)31-21-28-12-23(32-21)5-8-33(9-6-23)15(35)11-13-1-3-14(4-2-13)34-10-7-27-22(34)37;22-15-17(27)30-16(26)14(29-15)18(35)31-19-28-10-20(32-19)5-7-33(8-6-20)13(34)9-36-11-1-3-12(4-2-11)37-21(23,24)25;1-35(33,34)13-4-2-12(3-5-13)10-14(31)30-8-6-21(7-9-30)11-25-20(29-21)28-19(32)15-17(23)27-18(24)16(22)26-15/h1-5,14H,6-13H2,(H4,27,28,31)(H,29,32,36);2-5H,6-12H2,1H3,(H4,26,27,31)(H2,28,32,33,37);1-4H,5-12H2,(H,27,37)(H4,25,26,30)(H2,28,31,32,36);1-4H,5-10H2,(H4,26,27,30)(H2,28,31,32,35);2-5H,6-11H2,1H3,(H4,23,24,27)(H2,25,28,29,32)
InChIKeyYSJHOFFRPGZSGJ-UHFFFAOYSA-N
XLogP5.33
TPSA905.19 Ų
H-Bond Donors20
H-Bond Acceptors50
Rotatable Bonds24
Heavy Atoms185
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002668.89
LogP ≤ 55.33
H-Bond Donors ≤ 520
H-Bond Acceptors ≤ 1050

Analyze 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide?
The IUPAC name of 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide (CID 162002275) is 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide.
What is the SMILES notation for 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide?
The canonical SMILES for 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide is COc1ccc(-c2noc(CCC(=O)N3CCC4(CC3)CN=C(NC(=O)c3nc(Cl)c(N)nc3N)N4)n2)cc1.CS(=O)(=O)c1ccc(CC(=O)N2CCC3(CC2)CN=C(NC(=O)c2nc(Cl)c(N)nc2N)N3)cc1.Nc1nc(N)c(C(=O)NC2=NC3(CC2)CCN(C(=O)CCc2cc(-c4ccccc4)no2)CC3)nc1Cl.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)COc4ccc(OC(F)(F)F)cc4)CC3)N2)nc1Cl.Nc1nc(N)c(C(=O)NC2=NCC3(CCN(C(=O)Cc4ccc(N5CCNC5=O)cc4)CC3)N2)nc1Cl.
What is the InChIKey of 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide?
The InChIKey is YSJHOFFRPGZSGJ-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H27ClN8O3.C24H27ClN10O4.C23H27ClN10O3.C21H22ClF3N8O4.C21H25ClN8O4S/c26-21-23(28)31-22(27)20(30-21)24(36)29-18-8-9-25(32-18)10-12-34(13-11-25)19(35)7-6-16-14-17(33-37-16)15-4-2-1-3-5-15;1-38-14-4-2-13(3-5-14)21-29-15(39-34-21)6-7-16(36)35-10-8-24(9-11-35)12-28-23(33-24)32-22(37)17-19(26)31-20(27)18(25)30-17;24-17-19(26)30-18(25)16(29-17)20(36)31-21-28-12-23(32-21)5-8-33(9-6-23)15(35)11-13-1-3-14(4-2-13)34-10-7-27-22(34)37;22-15-17(27)30-16(26)14(29-15)18(35)31-19-28-10-20(32-19)5-7-33(8-6-20)13(34)9-36-11-1-3-12(4-2-11)37-21(23,24)25;1-35(33,34)13-4-2-12(3-5-13)10-14(31)30-8-6-21(7-9-30)11-25-20(29-21)28-19(32)15-17(23)27-18(24)16(22)26-15/h1-5,14H,6-13H2,(H4,27,28,31)(H,29,32,36);2-5H,6-12H2,1H3,(H4,26,27,31)(H2,28,32,33,37);1-4H,5-12H2,(H,27,37)(H4,25,26,30)(H2,28,31,32,36);1-4H,5-10H2,(H4,26,27,30)(H2,28,31,32,35);2-5H,6-11H2,1H3,(H4,23,24,27)(H2,25,28,29,32).
What are the key properties of 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide?
3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide has a molecular weight of 2668.89 g/mol, XLogP of 5.33, 24 rotatable bonds, 20 hydrogen bond donors, and 50 hydrogen bond acceptors.
Where does this data come from?
All data for 3,5-diamino-6-chloro-N-[8-[3-[3-(4-methoxyphenyl)-1,2,4-oxadiazol-5-yl]propanoyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-(4-methylsulfonylphenyl)acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(2-oxoimidazolidin-1-yl)phenyl]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[3-(3-phenyl-1,2-oxazol-5-yl)propanoyl]-1,8-diazaspiro[4.5]dec-1-en-2-yl]pyrazine-2-carboxamide;3,5-diamino-6-chloro-N-[8-[2-[4-(trifluoromethoxy)phenoxy]acetyl]-1,3,8-triazaspiro[4.5]dec-2-en-2-yl]pyrazine-2-carboxamide is sourced from PubChem (CID 162002275), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).